The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC).
 
Tanya Kwan
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Amit M. Oza
(OPTIONAL) Uncompensated Relationships - Ozmosis Research
 
Domenica Lorusso
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck Serono; MSD
Consulting or Advisory Role - PharmaMar
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD
Research Funding - Clovis Oncology (Inst); GlaxoSmithKline (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; GlaxoSmithKline; PharmaMar; Roche
 
Carol Aghajanian
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; Eisai; Eisai; Mersana; Repare Therapeutics; Roche; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Immunogen; Mersana; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Andrew Peter Dean
Travel, Accommodations, Expenses - Novartis; Novartis
 
Nicoletta Colombo
Honoraria - Amgen; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; mersana; MSD Oncology; Novartis; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; MSD Oncology; Pfizer; Pfizer; PharmaMar; Roche/Genentech; Tesaro
 
Johanne I Weberpals
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Andrew R. Clamp
Consulting or Advisory Role - AstraZeneca; Eisai Europe; GlaxoSmithKline
Speakers' Bureau - Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); Lilly (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Giovanni Scambia
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Speakers' Bureau - Clovis Oncology; MSD
 
Alexandra Leary
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - Ability Pharma (Inst); AstraZeneca (Inst); BioCad; Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); Tesaro (Inst); zentalis
Research Funding - GamaMabs Pharma (Inst); Inivata (Inst); Merus (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Robert W. Holloway
Consulting or Advisory Role - Abbvie; Clovis Oncology
Speakers' Bureau - AstraZeneca; Bard/Davol; Clovis Oncology; Tesaro
 
Margarita Amenedo
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Lilly; Roche
 
Peter C.C. Fong
Consulting or Advisory Role - MSD; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Jeffrey C. Goh
Stock and Other Ownership Interests - Immutep
Honoraria - Ipsen
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - AstraZeneca; Ipsen; Janssen; Mundipharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
David M. O'Malley
Consulting or Advisory Role - Abbvie; Agenus; Ambry Genetics; AstraZeneca; Clovis Oncology; Eisai; Elevar Therapeutics; Genelux; Genentech/Roche; GlaxoSmithKline; GOG Foundation; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Leap Therapeutics; Marker Therapeutics; Myriad Genetics; Novartis; Novocure; OncoQuest; Regeneron; Rubius Therapeutics; Rubius Therapeutics; Seagen; Sorrento Therapeutics; Tarveda Therapeutics; Tesaro; Translational Genomics Research Institute
Research Funding - Abbvie (Inst); Abbvie/Stemcentrx (Inst); Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); Eisai (Inst); Eisai (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Leap Therapeutics (Inst); Merck (Inst); Mersana (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Tesaro (Inst); TRACON Pharma (Inst)
 
Lara Maloney
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Jonathan A. Ledermann
Consulting or Advisory Role - Amgen; Artios; AstraZeneca/MedImmune; Clovis Oncology; Eisai; Merck; Pfizer; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Pfizer; Tesaro/GSK
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
Other Relationship - Regeneron
 
Robert L. Coleman
Employment - US Oncology
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group